IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 138 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $252,000 | -11.3% | 24,400 | +58.4% | 0.02% | -23.3% |
| Q3 2018 | $284,000 | +142.7% | 15,400 | +43.6% | 0.03% | +400.0% |
| Q1 2016 | $117,000 | -87.7% | 10,725 | -86.9% | 0.01% | -85.0% |
| Q4 2015 | $948,000 | -82.9% | 81,762 | -77.3% | 0.04% | -82.9% |
| Q2 2014 | $5,530,000 | -90.3% | 360,724 | -92.2% | 0.23% | -90.1% |
| Q1 2014 | $57,192,000 | -3.1% | 4,642,182 | -8.7% | 2.35% | -7.6% |
| Q4 2013 | $59,037,000 | +3.9% | 5,084,999 | +5.9% | 2.55% | -6.9% |
| Q3 2013 | $56,830,000 | +12.4% | 4,799,848 | -5.7% | 2.73% | +82.9% |
| Q2 2013 | $50,544,000 | – | 5,090,047 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |